IONS: HC Wainwright Raises PT
HC Wainwright & Co. maintains Buy on Ionis Pharmaceuticals and raises price target to $130
HC Wainwright & Co. analyst Mitchell S.
Kapoor maintains Ionis Pharmaceuticals (NASDAQ: IONS ) with a Buy and raises the price target from $125 to $130.